Chris McFadden, Managing Director at KKR, a leading global investment firm working with healthcare companies. Chris is also a founding member of the COVID Patient Recovery Alliance, a contributing author to MedCity, and a board member of several medical and healthcare companies. Chris discusses what it means to work at a global investment firm, which leads to some big questions about medicine in a post-pandemic world. What are the benefits and drawbacks of telemedicine? How will increased awareness of mental illness affect medical systems? And how can healthcare companies continue to adapt as the world re-opens?